Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001571469-24-000001
Filing Date
2024-11-20
Accepted
2024-11-19 19:06:32
Documents
1
Effectiveness Date
2024-11-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 11900
  Complete submission text file 0001571469-24-000001.txt   12990
Mailing Address 9171 TOWNE CENTRE DRIVE, SUITE 380 SAN DIEGO CA 92122
Business Address 9171 TOWNE CENTRE DRIVE, SUITE 380 SAN DIEGO CA 92122 (386) 303-1178
Avenzo Therapeutics, Inc. (Filer) CIK: 0001947742 (see all company filings)

EIN.: 883737798 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-460216 | Film No.: 241477809